日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Harnessing endogenous anti-glycan antibodies using a novel, bifunctional immunotherapy to treat gram-negative bacterial infections.

利用新型双功能免疫疗法,发挥内源性抗聚糖抗体治疗革兰氏阴性菌感染

Hairsine Bailey, Leire Emma, Rostam Hassan M, Kristian Sascha A, Rhodes Edward, Johnson Adam, Bushdyhan Matthew, Chapman David, Pickford Chris, Westby Mike, Bright Helen

Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site

筛选、优化并研究一种新型高效抗病毒锁核酸反义寡核苷酸靶向丙型肝炎病毒内部核糖体进入位点的药代动力学特性

Laxton, Carl; Brady, Kevin; Moschos, Sterghios; Turnpenny, Paul; Rawal, Jaiessh; Pryde, David C; Sidders, Ben; Corbau, Romu; Pickford, Chris; Murray, E J

Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action

靶向丙型肝炎病毒编码的NS5A的小分子可引起其靶点的亚细胞重分布:对化合物作用机制的深入理解

Targett-Adams, Paul; Graham, Emily J S; Middleton, Jenny; Palmer, Amy; Shaw, Stephen M; Lavender, Helen; Brain, Philip; Tran, Thien Duc; Jones, Lyn H; Wakenhut, Florian; Stammen, Blanda; Pryde, David; Pickford, Chris; Westby, Mike

New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation.

一种靶向人类免疫缺陷病毒1型病毒颗粒成熟的新型小分子抑制剂

Blair Wade S, Cao Joan, Fok-Seang Juin, Griffin Paul, Isaacson Jason, Jackson R Lynn, Murray Edward, Patick Amy K, Peng Qinghai, Perros Manos, Pickford Chris, Wu Hua, Butler Scott L